Efficacy of a new small-molecule inhibitor of histone deacetylase 6 (HDAC6) in preclinical models of B-cell lymphoma and acute myeloid leukemia

被引：0

作者：

Villanueva, Lorea ^{[1
]}

Perez-Salvia, Montserrat ^{[1
]}

Aldaba, Eneko ^{[2
]}

Vara, Yosu ^{[2
]}

Fabre, Myriam ^{[3
]}

Ferrer, Cristina ^{[3
]}

Masdeu, Carme ^{[4
]}

Zubia, Aizpea ^{[4
]}

San Sebastian, Eider ^{[4
]}

Otaegui, Dorleta ^{[5
]}

Llinas-Arias, Pere ^{[1
]}

Rossello-Tortella, Margalida ^{[1
]}

Berdasco, Maria ^{[1
]}

Setien, Fernando ^{[1
]}

Moutinho, Catia ^{[1
]}

Villanueva, Alberto ^{[6
]}

Gonzalez-Barca, Eva ^{[6
]}

Muncunill, Josep ^{[7
]}

Tomas Navarro, Jose ^{[7
]}

Angel Piris, Miguel ^{[8
]}

Cossio, Fernando ^{[4
]}

Esteller, Manel ^{[1
]}

机构：

[1] Canc Epigenet & Biol Program PEBC, Barcelona, Spain

[2] Quimatryx, San Sebastian, Spain

[3] Oncomatryx, Derio, Spain

[4] Univ Basque Country, San Sebastian, Spain

[5] CIC BiomaGUNE, San Sebastian, Spain

[6] Catalan Inst Oncol ICO, Barcelona, Spain

[7] Josep Carreras Res Inst IJC, Badalona, Spain

[8] Fdn Jimenez Diaz, Madrid, Spain

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.SABCS18-4725

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4725

引用

页数：2

共 50 条

[41] Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6
McCoull, William
Cheung, Tony
Anderson, Erica
Barton, Peter
Burgess, Jonathan
Byth, Kate
Cao, Qing
Castald, M. Paola
Chen, Huawei
Chiarparin, Elisabetta
Carbajo, Rodrigo J.
Code, Erin
Cowan, Suzanna
Davey, Paul R.
Ferguson, Andrew D.
Fillery, Shaun
Fuller, Nathan O.
Gao, Ning
Hargreaves, David
Howard, Martin R.
Hu, Jun
Kawatkar, Aarti
Kemmitt, Paul D.
Leo, Elisabetta
Molina, Daniel M.
O'Conne', Nichole
Petteruti, Philip
Rasmusson, Timothy
Raubo, Piotr
Rawlins, Philip B.
Ricchiuto, Piero
Robb, Graeme R.
Schenone, Monica
Waring, Michael J.
Zinda, Michael
Fawell, Stephen
Wilson, David M.
[J]. ACS CHEMICAL BIOLOGY, 2018, 13 (11) : 3131 - 3141
[42] Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia
George, Aswathi A.
Paz, Helicia
Fei, Fei
Kirzner, Jonathan
Kim, Yong-Mi
Heisterkamp, Nora
Abdel-Azim, Hisham
[J]. PLOS ONE, 2015, 10 (09):
[43] Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphoma
Liu, Zebing
Cai, Ying
Yang, Yu
Li, Anqi
Bi, Rui
Wang, Lisha
Shen, Xiaohan
Wang, Weige
Jia, Yijun
Yu, Baohua
Cao, Bing
Cui, Wenli
Wei, Ping
Zhou, Xiaoyan
[J]. JOURNAL OF PATHOLOGY, 2018, 246 (02): : 141 - 153
[44] Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor Rocilinostat (ACY-1215) and Bortezomib, Demonstrates Synergistic Antitumor Activity in Preclinical Models of Lymphoma
Amengual, Jennifer E.
Johannet, Paul M.
Jones, Simon S.
O'Connor, Owen A.
[J]. BLOOD, 2012, 120 (21)
[45] Therapeutic Targeting of the Bcl-6: p53 Axis with Histone Deacetylase Inhibitors in Diffuse Large B-Cell Lymphoma
Amengual, Jennifer E.
Kalac, Matko
Scotto, Luigi
Sleckman, Patrick A.
Marchi, Enrica
Deng, Changchun
Bongero, Danielle C.
Jain, Salvia
Buitrago, Jairo Baquero
O'Connor, Owen A.
[J]. BLOOD, 2011, 118 (21) : 1593 - 1594
[46] miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model
Sandhu, Sukhinder K.
Volinia, Stefano
Costinean, Stefan
Galasso, Marco
Neinast, Reid
Santhanam, Ramasamy
Parthun, Mark R.
Perrotti, Danilo
Marcucci, Guido
Garzon, Ramiro
Croce, Carlo M.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (49) : 20047 - 20052
[47] HDAC6 Regulates MicroRNA-27b that Suppresses Proliferation, Promotes Apoptosis and Target C-MET in Diffuse Large B-Cell Lymphoma
Jia, Y.
Liu, Z.
Zhou, X.
[J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 965 - 965
[48] Vorinostat, a Histone Deacetylase (HDAC) Inhibitor, Is Active in Chemotherapy Resistant B-Cell Non-Hodgkin Lymphoma and Enhances the Anti-Tumor Activity of Chemotherapy Agents
Xue, Kai
Gu, Juan
Mavis, Cory
Hernandez, Francisco
Czuczman, Myron S.
Guo, Ye
[J]. BLOOD, 2014, 124 (21)
[49] Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells
María G. Cortiguera
Lorena García-Gaipo
Simon D. Wagner
Javier León
Ana Batlle-López
M. Dolores Delgado
[J]. Scientific Reports, 9
[50] Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells
Cortiguera, Maria G.
Garcia-Gaipo, Lorena
Wagner, Simon D.
Leon, Javier
Batlle-Lopez, Ana
Dolores Delgado, M.
[J]. SCIENTIFIC REPORTS, 2019, 9 (1)

← 1 2 3 4 5 →